$6.95
+8.68%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$6.20
From 52W high−54.93%
Volume81376.00
Market cap$492.36M
P/E (TTM)—
P/S (TTM)825.0x
Div yield—
Key dataNov 4, 2026
Open
$6.20
From 52W high
−54.93%
Volume
81376.00
Market cap
$492.36M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−60.8x
P/E (TTM)
—
RSI (14)
55.4
MomentumView details →
1D Return
+8.68%
YTD Return
−47.99%
Similar companies
Latest newsMore news →
YD Bio Ltd and EG BioMed announced a collaboration with R Bio Co., Ltd. to integrate their jointly developed AI Cancer Risk Assessment into R Bio Co., Ltd.’s JoiiSports app for corporate wellness programs and healthcare institutions.15d agoYD Bio Limited and EG BioMed Co., Ltd. launched an AI-based 10-cancer risk factor assessment.29d agoYD Bio Limited announced its unaudited financial results for the six months ended June 30, 2026.65d ago